[go: up one dir, main page]

JP2000508654A - Ｄｈｅａ組合せ療法 - Google Patents

Ｄｈｅａ組合せ療法

Info

Publication number
JP2000508654A
JP2000508654A JP9536909A JP53690997A JP2000508654A JP 2000508654 A JP2000508654 A JP 2000508654A JP 9536909 A JP9536909 A JP 9536909A JP 53690997 A JP53690997 A JP 53690997A JP 2000508654 A JP2000508654 A JP 2000508654A
Authority
JP
Japan
Prior art keywords
interleukin
group
treatment
patient
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9536909A
Other languages
English (en)
Japanese (ja)
Inventor
プレンデルガスト，パトリック，ティー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2000508654A publication Critical patent/JP2000508654A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP9536909A 1996-04-17 1997-04-17 Ｄｈｅａ組合せ療法 Pending JP2000508654A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1569596P 1996-04-17 1996-04-17
US60/015,695 1996-04-17
PCT/IB1997/000414 WO1997038695A1 (fr) 1996-04-17 1997-04-17 Therapie associee reposant sur l'utilisation de la dehydroepiandrosterone (dhea)

Publications (1)

Publication Number Publication Date
JP2000508654A true JP2000508654A (ja) 2000-07-11

Family

ID=21773003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9536909A Pending JP2000508654A (ja) 1996-04-17 1997-04-17 Ｄｈｅａ組合せ療法

Country Status (9)

Country Link
EP (1) EP0901375A1 (fr)
JP (1) JP2000508654A (fr)
KR (1) KR20000005539A (fr)
CN (1) CN1216470A (fr)
AU (1) AU734807B2 (fr)
CA (1) CA2251733A1 (fr)
IL (1) IL126623A0 (fr)
NO (1) NO984851L (fr)
WO (1) WO1997038695A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1348373A (zh) * 1998-11-24 2002-05-08 霍利斯-伊登医药公司 17－酮甾类化合物及其衍生物、代谢产物和前体在疟疾的治疗以及非洲和美洲锥虫病的治疗中的应用
ID29864A (id) * 1998-11-24 2001-10-18 Hollis Eden Pharmaceuticals Penggunaan senyawa turunan 17-ketosteroid dan turunan, metabolit dan prekursornya dalam pengobatan virus hepatitis c dan togavirus lain
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
CA2352387A1 (fr) * 1998-11-27 2000-06-08 Hollis-Eden Pharmaceuticals, Inc. Utilisation de composes 17-cetosteroides et de leurs derives, metabolites et precurseurs pour le traitement de la toxoplasmose ou de la cryptosporidiose
WO2014166501A2 (fr) * 2013-04-10 2014-10-16 Skau Aps Utilisation de peptides immunosuppresseurs en tant qu'adjuvants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3815472A1 (de) * 1988-05-06 1989-11-16 Centre Regional De Transfusion Monoklonaler antikoerper und seine verwendung
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)
EP0671933B1 (fr) * 1992-08-20 1998-02-04 Schering Corporation Nouvelles utilisations d'il-10
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
NO984851L (no) 1998-12-17
AU2574197A (en) 1997-11-07
KR20000005539A (ko) 2000-01-25
IL126623A0 (en) 1999-08-17
WO1997038695A1 (fr) 1997-10-23
CN1216470A (zh) 1999-05-12
CA2251733A1 (fr) 1997-10-23
EP0901375A1 (fr) 1999-03-17
NO984851D0 (no) 1998-10-16
AU734807B2 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
KR102102677B1 (ko) 포르볼 에스테르의 조성물
JP2020037569A (ja) ホルボールエステルを含む組成物及びその使用法
JPH06172183A (ja) 医薬組成物
KR20250048489A (ko) 줄기 세포 이식을 위한 방법
KR20010072957A (ko) Ｈ2 수용체 작용제 및 기타 ｔ-세포 활성화제를 사용한ｔ-세포(ｃｄ4+ 및 ｃｄ8+) 활성화 및 보호 방법
Gelfand et al. Partial purine nucleoside phosphorylase deficiency: Studies of lymphocyte function
EP4547334A1 (fr) Formes solides d'un analogue nucléosidique et leurs utilisations
US10413586B2 (en) Antiviral agent comprising recombinant mistletoe lectins
KR20020016844A (ko) 반응성 산소 대사산물 저해제를 이용한 세포독성 림프구의활성화 및 보호
US20070071717A1 (en) Treatment of B cells with IL-21 and B cell activators induces Granzyme B production
EP0311616A1 (fr) Combinaisons d'interferons gamma et d'agents anti-inflammatoires ou anti-pyretiques pour le traitement de maladies.
JP2000508654A (ja) Ｄｈｅａ組合せ療法
US20140011755A1 (en) Cardiac Glycosides for Treating Autoimmune Disease
AU602492B2 (en) Process for treatment of allergies
WO1998047516A1 (fr) Therapie combinee mettant en application des 17-cetosteroides et des inhibiteurs d'interleukine, ou interleukine-10 eventuellement avec des inhibiteurs d'interleukine
EP2338497A1 (fr) Traitement et prévention des maladies et troubles liés à une protéine de choc thermique
AU726909B2 (en) Therapeutic uses for an aminosterol compound
Parr et al. Allogeneic bone marrow transplantation: procedures and complications
Keane et al. Progressive vaccinia associated with combined variable immunodeficiency
US20230183370A1 (en) Stem cell immunomodulatory therapy for covid-19 infection
US11452724B2 (en) Methods for treating amyotrophic lateral sclerosis
CN112656801A (zh) 孕激素在治疗细胞因子释放综合征中的应用
JPH01313433A (ja) 抗ｈｉｖ剤
Bartlett et al. Coadministration of zidovudine and interleukin-2 increases absolute CD4 cells in subjects with Walter Reed stage 2 human immunodeficiency virus infection: results of ACTG protocol 042
JPH10501217A (ja) Ｈｉｖの被爆後阻止